Global Human Serum Albumin Fusion Protein Drug Industry Research & Trends Analysis Report
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to A Latest intelligence report published by Market IntelliX, the global market for Human Serum Albumin Fusion Protein Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Human Serum Albumin Fusion Protein Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Human Serum Albumin Fusion Protein Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Idelvion segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hemophilia has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Human Serum Albumin Fusion Protein Drug include GSK and CSL Behring etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Fusion proteins have been well-studied and widely applied in biopharmaceutics. Albumin fusion proteins are simple to construct, easy to purify, and stable to formulate.
This report aims to provide a comprehensive study of the global market for Human Serum Albumin Fusion Protein Drug. Report Highlights:
(1) Global Human Serum Albumin Fusion Protein Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Human Serum Albumin Fusion Protein Drug market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Human Serum Albumin Fusion Protein Drug market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Human Serum Albumin Fusion Protein Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Human Serum Albumin Fusion Protein Drug segment by type and by application and regional segment by type and by application.
(6) Human Serum Albumin Fusion Protein Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Idelvion
Tanzeum
Market segment by application, can be divided into
Hemophilia
Diabetes
Other
Market segment by players, this report covers
GSK
CSL Behring
1 Market Overview
1.1 Product Overview and Scope of Human Serum Albumin Fusion Protein Drug
1.2 Global Human Serum Albumin Fusion Protein Drug Market Size and Forecast
1.3 China Human Serum Albumin Fusion Protein Drug Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Human Serum Albumin Fusion Protein Drug Share in Global Market, 2018-2029
1.4.2 Human Serum Albumin Fusion Protein Drug Market Size: China VS Global, 2018-2029
1.5 Human Serum Albumin Fusion Protein Drug Market Dynamics
1.5.1 Human Serum Albumin Fusion Protein Drug Market Drivers
1.5.2 Human Serum Albumin Fusion Protein Drug Market Restraints
1.5.3 Human Serum Albumin Fusion Protein Drug Industry Trends
1.5.4 Human Serum Albumin Fusion Protein Drug Industry Policy
2 Global Competitive Situation by Company
2.1 Global Human Serum Albumin Fusion Protein Drug Revenue by Company (2018-2023)
2.2 Global Human Serum Albumin Fusion Protein Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Human Serum Albumin Fusion Protein Drug Concentration Ratio
2.4 Global Human Serum Albumin Fusion Protein Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Human Serum Albumin Fusion Protein Drug Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Human Serum Albumin Fusion Protein Drug Revenue by Company (2018-2023)
3.2 China Human Serum Albumin Fusion Protein Drug Human Serum Albumin Fusion Protein Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Human Serum Albumin Fusion Protein Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Human Serum Albumin Fusion Protein Drug Industry Chain
4.2 Human Serum Albumin Fusion Protein Drug Upstream Analysis
4.3 Human Serum Albumin Fusion Protein Drug Midstream Analysis
4.4 Human Serum Albumin Fusion Protein Drug Downstream Analysis
5 Sights by Type
5.1 Human Serum Albumin Fusion Protein Drug Classification
5.1.1 Idelvion
5.1.2 Tanzeum
5.2 By Type, Global Human Serum Albumin Fusion Protein Drug Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029
6 Sights by Application
6.1 Human Serum Albumin Fusion Protein Drug Segment by Application
6.1.1 Hemophilia
6.1.2 Diabetes
6.1.3 Other
6.2 By Application, Global Human Serum Albumin Fusion Protein Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Human Serum Albumin Fusion Protein Drug Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
7.3 North America
7.3.1 North America Human Serum Albumin Fusion Protein Drug Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Human Serum Albumin Fusion Protein Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Human Serum Albumin Fusion Protein Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Human Serum Albumin Fusion Protein Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Human Serum Albumin Fusion Protein Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Human Serum Albumin Fusion Protein Drug Market Size Market Share
7.6 South America
7.6.1 South America Human Serum Albumin Fusion Protein Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Human Serum Albumin Fusion Protein Drug Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Human Serum Albumin Fusion Protein Drug Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
8.3.2 By Company, U.S. Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
8.4.2 By Company, Europe Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
8.5.2 By Company, China Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
8.5.3 By Type, China Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
8.6.2 By Company, Japan Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
8.7.2 By Company, South Korea Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
8.9.2 By Company, India Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
8.9.3 By Type, India Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Human Serum Albumin Fusion Protein Drug Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 GSK
9.1.1 GSK Company Information, Head Office, Market Area and Industry Position
9.1.2 GSK Company Profile and Main Business
9.1.3 GSK Human Serum Albumin Fusion Protein Drug Models, Specifications and Application
9.1.4 GSK Human Serum Albumin Fusion Protein Drug Revenue and Gross Margin, 2018-2023
9.1.5 GSK Recent Developments
9.2 CSL Behring
9.2.1 CSL Behring Company Information, Head Office, Market Area and Industry Position
9.2.2 CSL Behring Company Profile and Main Business
9.2.3 CSL Behring Human Serum Albumin Fusion Protein Drug Models, Specifications and Application
9.2.4 CSL Behring Human Serum Albumin Fusion Protein Drug Revenue and Gross Margin, 2018-2023
9.2.5 CSL Behring Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Human Serum Albumin Fusion Protein Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Human Serum Albumin Fusion Protein Drug Market Restraints
Table 3. Human Serum Albumin Fusion Protein Drug Market Trends
Table 4. Human Serum Albumin Fusion Protein Drug Industry Policy
Table 5. Global Human Serum Albumin Fusion Protein Drug Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Company (2018-2023)
Table 7. Global Human Serum Albumin Fusion Protein Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Human Serum Albumin Fusion Protein Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Human Serum Albumin Fusion Protein Drug Manufacturers Product Type
Table 10. China Human Serum Albumin Fusion Protein Drug Revenue by Company (2018-2023) & (US$ million)
Table 11. China Human Serum Albumin Fusion Protein Drug Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Human Serum Albumin Fusion Protein Drug Upstream (Raw Materials)
Table 13. Global Human Serum Albumin Fusion Protein Drug Typical Customers
Table 14. Human Serum Albumin Fusion Protein Drug Typical Distributors
Table 15. By Type, Global Human Serum Albumin Fusion Protein Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Human Serum Albumin Fusion Protein Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Human Serum Albumin Fusion Protein Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Human Serum Albumin Fusion Protein Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2029
Table 22. GSK Company Information, Head Office, Market Area and Industry Position
Table 23. GSK Company Profile and Main Business
Table 24. GSK Human Serum Albumin Fusion Protein Drug Models, Specifications and Application
Table 25. GSK Human Serum Albumin Fusion Protein Drug Revenue and Gross Margin, 2018-2023
Table 26. GSK Recent Developments
Table 27. CSL Behring Company Information, Head Office, Market Area and Industry Position
Table 28. CSL Behring Company Profile and Main Business
Table 29. CSL Behring Human Serum Albumin Fusion Protein Drug Models, Specifications and Application
Table 30. CSL Behring Human Serum Albumin Fusion Protein Drug Revenue and Gross Margin, 2018-2023
Table 31. CSL Behring Recent Developments
List of Figure
Figure 1. Human Serum Albumin Fusion Protein Drug Picture
Figure 2. Global Human Serum Albumin Fusion Protein Drug Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Human Serum Albumin Fusion Protein Drug Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Human Serum Albumin Fusion Protein Drug Market Share of Global
Figure 5. Global Human Serum Albumin Fusion Protein Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Human Serum Albumin Fusion Protein Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Human Serum Albumin Fusion Protein Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Human Serum Albumin Fusion Protein Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Human Serum Albumin Fusion Protein Drug Industry Chain
Figure 10. Idelvion
Figure 11. Tanzeum
Figure 12. By Type, Global Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2029
Figure 14. Hemophilia
Figure 15. Diabetes
Figure 16. Other
Figure 17. By Application, Global Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, US$ Million
Figure 18. By Application, Global Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2029
Figure 19. By Region, Global Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2029
Figure 20. North America Human Serum Albumin Fusion Protein Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 21. By Country, North America Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
Figure 22. Europe Human Serum Albumin Fusion Protein Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, Europe Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
Figure 24. Asia Pacific Human Serum Albumin Fusion Protein Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country/Region, Asia Pacific Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
Figure 26. South America Human Serum Albumin Fusion Protein Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, South America Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2018-2023
Figure 28. Middle East & Africa Human Serum Albumin Fusion Protein Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. U.S. Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, (US$ Million)
Figure 30. By Company, U.S. Human Serum Albumin Fusion Protein Drug Market Share, 2018-2023
Figure 31. By Type, U.S. Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 33. Europe Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, (US$ Million)
Figure 34. By Company, Europe Human Serum Albumin Fusion Protein Drug Market Share, 2018-2023
Figure 35. By Type, Europe Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 36. By Application, Europe Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 37. China Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, (US$ Million)
Figure 38. By Company, China Human Serum Albumin Fusion Protein Drug Market Share, 2018-2023
Figure 39. By Type, China Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 40. By Application, China Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 41. Japan Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, (US$ Million)
Figure 42. By Company, Japan Human Serum Albumin Fusion Protein Drug Market Share, 2018-2023
Figure 43. By Type, Japan Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 44. By Application, Japan Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 45. South Korea Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, (US$ Million)
Figure 46. By Company, South Korea Human Serum Albumin Fusion Protein Drug Market Share, 2018-2023
Figure 47. By Type, South Korea Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 48. By Application, South Korea Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 49. Southeast Asia Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, (US$ Million)
Figure 50. By Company, Southeast Asia Human Serum Albumin Fusion Protein Drug Market Share, 2018-2023
Figure 51. By Type, Southeast Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 52. By Application, Southeast Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 53. India Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, (US$ Million)
Figure 54. By Company, India Human Serum Albumin Fusion Protein Drug Market Share, 2018-2023
Figure 55. By Type, India Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 56. By Application, India Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 57. Middle East & Asia Human Serum Albumin Fusion Protein Drug Revenue, 2018-2029, (US$ Million)
Figure 58. By Company, Middle East & Asia Human Serum Albumin Fusion Protein Drug Market Share, 2018-2023
Figure 59. By Type, Middle East & Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 60. By Application, Middle East & Asia Human Serum Albumin Fusion Protein Drug Revenue Market Share, 2022 VS 2029
Figure 61. Research Methodology
Figure 62. Breakdown of Primary Interviews
Figure 63. Bottom-up Approaches
Figure 64. Top-down Approaches
Research Methodology:
Human Serum Albumin Fusion Protein Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|